Work

1127P Correlation of BRAF mutation status in circulating tumour DNA (ctDNA) with tumour biopsy and clinical outcomes in COLUMBUS

Year: 2020

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2020.08.1250

Authors: C. Robert, K.T. Flaherty, H.J. Gogas, A.M. Arance Fernandez, M. Mandala, G. Liszkay, C. Garbe, D. Schadendorf, I. Krajsova, R. Gutzmer, J.W.B. de Groot, C. Dutriaux, C. Loquai, A. Harney, E. Kiprilov, M.D. Pickard, J. Cantey-Kiser, R. Dummer, P.A. Ascierto

Institutions: Université Paris-Sud, Massachusetts General Hospital, National and Kapodistrian University of Athens, Hospital Clínic de Barcelona, Ospedale Papa Giovanni XXIII, National Institute of Oncology, Universitätsklinikum Tübingen, University of Tübingen, Essen University Hospital, Charles University, Isala, Centre Hospitalier Universitaire de Bordeaux, University Medical Center of the Johannes Gutenberg University Mainz, Pfizer (United States), Duke University, University of Zurich, University Hospital Zurich, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Pfizer

OpenAlex ID: W3088006236

FWCI:

Cites:

Cited by:

Related to: 10